Despite the recent approval of some high-profile nucleic acid therapy drugs, success has been modest, and there is still a “huge burden” of unmet medical need due to the vast number of diseases that are untreatable with traditional therapies.
Original Article: UKRI launches ‘Nucleic Acid Therapy Accelerator’